BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11979416)

  • 1. Gastric cancer--patterns of relapse after surgical resection.
    Gunderson LL
    Semin Radiat Oncol; 2002 Apr; 12(2):150-61. PubMed ID: 11979416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of radiation therapy in gastric cancer.
    Willett CG
    Semin Radiat Oncol; 2002 Apr; 12(2):170-5. PubMed ID: 11979418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation treatment parameters in the adjuvant postoperative therapy of gastric cancer.
    Tepper JE; Gunderson LL
    Semin Radiat Oncol; 2002 Apr; 12(2):187-95. PubMed ID: 11979420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in the treatment of gastric cancer.
    Roukos DH; Kappas AM
    Nat Clin Pract Oncol; 2005 Feb; 2(2):98-107. PubMed ID: 16264882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.
    Sakamoto J; Morita S; Kodera Y; Rahman M; Nakao A
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S25-31. PubMed ID: 15309511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
    Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
    Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.
    Liu TS; Wang Y; Chen SY; Sun YH
    Eur J Surg Oncol; 2008 Nov; 34(11):1208-16. PubMed ID: 18353606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative chemotherapy for gastric cancer.
    Hejna M; Wöhrer S; Schmidinger M; Raderer M
    Oncologist; 2006 Feb; 11(2):136-45. PubMed ID: 16476834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of surgical traumaticity of standard and extended surgical procedures in cancer of a proximal part of the stomach].
    Aĭtaliev MS; Zemlianoĭ VP; Nepomniashchaia SL
    Khirurgiia (Mosk); 2005; (3):23-6. PubMed ID: 15798735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
    Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
    Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.